1. Home
  2. UG vs CLGN Comparison

UG vs CLGN Comparison

Compare UG & CLGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UG
  • CLGN
  • Stock Information
  • Founded
  • UG 1942
  • CLGN 2004
  • Country
  • UG United States
  • CLGN Israel
  • Employees
  • UG N/A
  • CLGN N/A
  • Industry
  • UG Package Goods/Cosmetics
  • CLGN Industrial Specialties
  • Sector
  • UG Consumer Discretionary
  • CLGN Health Care
  • Exchange
  • UG Nasdaq
  • CLGN Nasdaq
  • Market Cap
  • UG 32.9M
  • CLGN 33.8M
  • IPO Year
  • UG N/A
  • CLGN N/A
  • Fundamental
  • Price
  • UG $5.92
  • CLGN $2.04
  • Analyst Decision
  • UG
  • CLGN Strong Buy
  • Analyst Count
  • UG 0
  • CLGN 2
  • Target Price
  • UG N/A
  • CLGN $11.50
  • AVG Volume (30 Days)
  • UG 9.6K
  • CLGN 22.0K
  • Earning Date
  • UG 11-06-2025
  • CLGN 11-26-2025
  • Dividend Yield
  • UG 11.67%
  • CLGN N/A
  • EPS Growth
  • UG N/A
  • CLGN N/A
  • EPS
  • UG 0.43
  • CLGN N/A
  • Revenue
  • UG $10,060,322.00
  • CLGN $2,402,000.00
  • Revenue This Year
  • UG N/A
  • CLGN $1,617.28
  • Revenue Next Year
  • UG N/A
  • CLGN $83.54
  • P/E Ratio
  • UG $14.15
  • CLGN N/A
  • Revenue Growth
  • UG N/A
  • CLGN 248.62
  • 52 Week Low
  • UG $5.97
  • CLGN $1.31
  • 52 Week High
  • UG $11.98
  • CLGN $4.98
  • Technical
  • Relative Strength Index (RSI)
  • UG 19.32
  • CLGN 40.20
  • Support Level
  • UG $6.05
  • CLGN $1.96
  • Resistance Level
  • UG $6.30
  • CLGN $2.20
  • Average True Range (ATR)
  • UG 0.22
  • CLGN 0.13
  • MACD
  • UG -0.06
  • CLGN 0.01
  • Stochastic Oscillator
  • UG 2.07
  • CLGN 33.34

About UG United-Guardian Inc.

United-Guardian Inc manufactures and markets cosmetic ingredients, pharmaceuticals, medical lubricants, and specialty industrial products. Its product portfolio includes Klensoft, Deselex, Renacidin, Lubrajel Fluid. The company's pharmaceutical products are sold to and distributed by full-line drug wholesalers throughout the United States. Its medical and specialty industrial products are sold directly by the company to the end-users of those products or, in some cases, to contract manufacturers used by some of those end users. It operates in one business segment and its current product lines are separated into four distinct product categories that are cosmetic ingredients, pharmaceuticals, medical lubricants and sexual wellness. It derives key revenue from the sales made in the U.S.

About CLGN CollPlant Biotechnologies Ltd

CollPlant Biotechnologies Ltd is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs and medical aesthetics. Its products are based on its rhCollagen (recombinant human collagen) produced with CollPlant's proprietary plant based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing. The revenues include income from business collaborators and sales of the BioInk product for the development of 3D bioprinting of organs and tissues, sales of rhCollagen for the medical aesthetics market, and sales in Europe of the products for tendinopathy and wound healing. The company operates in United States, which derives key revenue, Canada, Europe and Other, and Israel.

Share on Social Networks: